CMO, Hematology of Beigene, Ltd. (NASDAQ:BGNE), Huang Jane, sells 1,500 shares worth $373,690
According to Beigene, Ltd.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 04:34 PM, company CMO, Hematology, Huang Jane disclosed selling 1,500 shares at a cost of $249.13. At the time of this transaction (Dec 29), this trade was worth $373,690 in total. As of Dec 29, Huang Jane now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Beigene, Ltd. (NASDAQ:BGNE) CMO, Hematology, Huang Jane, we have the following information:
- SEC Form 4 filing: Sep 03: Sold 3,128 shares at the rate of $233.07 per share. Total worth of this trade was $729,045. Total number of shares owned as of Sep 03 were 0
- SEC Form 4 filing: Aug 28: Sold 3,000 shares at the rate of $242.21 per share. Total worth of this trade was $726,626. Total number of shares owned as of Aug 28 were 0
- SEC Form 4 filing: Jul 29: Sold 3,000 shares at the rate of $209.93 per share. Total worth of this trade was $629,787. Total number of shares owned as of Jul 29 were 0
Posted by
George Daniels
on Wednesday December 30 2020, 7:45 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
